What we do.

We focus on deploying capital via several investment strategies.

Fundamental, Qualitative and Quantitative Equity Long

Our fundamental, qualitative and quantitative equity long strategy uses rigorous fundamental research, qualitative analysis, and big data to identify small-cap publicly traded issuers whose stock is mispriced. Further analysis is made to narrow down the list to issuers who have upcoming catalysts with the potential of sending the issuers’ stock on an upward run of double or more within an eighteen-to-twenty-month time horizon.

We solely invest in disruptive innovation, therefore only focusing on issuers who we believe will transform their industry and who stand to benefit from technological, industry, regulatory, geopolitical, climate, cultural, consumer preference, microeconomic, or macroeconomic changes.

This strategy is executed by employing a highly concentrated portfolio and solely focusing on investing in issuers within the following industry sectors:

Fintech

Blockchain

Biotech

Ag-Bio

Clean Energy

Software

Artificial Intelligence

IoT

Autonomous Tech

Robotics

Healthcare

Infrastructure

Advertising & Media

Publicly Listed Issuer Financing & PIPE

Our publicly listed issuer financing and private investment in public equity (PIPE) strategy provides growth and working capital to small-cap, and microcap publicly listed issuers. Our in-depth regulatory compliance knowledge, and detailed understanding of clearance and settlement processes in multiple jurisdictions enable us to execute this strategy in the following markets:

  • NYSE
  • Nasdaq
  • OTC Markets
  • TSX Venture Exchange
  • CSE Canadian Securities Exchange
  • Bolsa Mexicana de Valores
  • B3 Brasil Bolsa Balcao
  • London Stock Exchange (AIM)
  • Borse Frankfurt
  • Bursa Efek Indonesia
  • Bombay Stock Exchange
  • STAR Market Shanghai

Our transactions are designed to provide issuers growth and working capital enabling them to:

  • Expand manufacturing capacity
  • Purchase or lease equipment and machinery
  • Acquire property
  • Add locations
  • Fund M&A transactions
  • Conduct clinical trials
  • Hire employees
  • Acquire patents, rights or licenses
  • Recapitalize their balance sheet

We are able to craft ideal financing structures utilizing debt, equity or other security instruments by working alongside issuers’ key decisionmakers. We can provide issuers with bridge financing in advance of larger funding rounds or to prepare an OTC Markets, TSX Venture Exchange or CSE Canadian Securities Exchange issuer for uplisting to the NYSE or Nasdaq. Each transaction is independently evaluated in order to tailor the financing to each issuers’ specific needs. Our experience, operational infrastructure, in-depth regulatory compliance knowledge, and detailed understanding of clearance and settlement processes allow us to execute transactions swiftly, and provide issuers with the capital they seek when they need it most.

Subprime Consumer Credit

Our subprime consumer credit strategy is implemented by purchasing portfolios of charged-off unsecured consumer debt (credit card, installment loan, cell phone and utility bill) and placing these debt portfolios with consumer debt collection agencies for liquidation. We utilize machine learning, proprietary algorithms and cutting-edge technology to evaluate the pricing, prospective recovery potential, litigation risk, alternative monetization and profitability of debt portfolios prior to making any investment.

Our in-depth understanding of credit bureau (Equifax, Experian and TransUnion) data furnishing, skip tracing, federal/state regulatory compliance, CFPB examinations, and relationships with credit grantors and debt buyers provide us an edge when employing this strategy.